Senores Pharmaceuticals Limited
SENORES · NSE · ₹1,350 a share (close of 01 Oct 2026)
Available company data, source links and archived checks for Senores Pharmaceuticals Limited. Read each source and date: a past check is not a fresh review, and some earlier figures have incomplete source details.
Revenue rose 30.6%; Net profit was ₹30.45 crore.
Quarter ended 2026-06-30 · consolidated · Company filing
Recorded quarterly figures
| Quarter | Revenue / income | YoY |
Profit | YoY | Net margin | Source |
|---|
| Jun 2026 | Revenue: ₹180 cr | +30.6% | Net profit: ₹30 cr | +43.8% | 16.9% | Company filing source |
| Mar 2026 | Revenue: ₹175 cr | +53.4% | Net profit: ₹37 cr | +104.1% | 20.9% | Company filing source |
| Dec 2025 | Revenue: ₹175 cr | — | Net profit: ₹34 cr | — | 19.2% | Company filing source |
| Sep 2025 | Revenue: ₹162 cr | — | Net profit: ₹30 cr | — | 18.6% | Company filing source |
| Jun 2025 | Revenue: ₹138 cr | — | Net profit: ₹21 cr | — | 15.3% | Company filing source |
| Mar 2025 | Revenue: ₹114 cr | — | Net profit: ₹18 cr | — | 15.7% | Company filing source |
YoY means change from the same quarter a year earlier.
— means no comparable figure is available. Older entries with incomplete source
details have not been revalidated under the current checks.
Who holds it — from the filings
Swapnil Jatin Shah 7.7%Ashokbhai Vijaysinh Barot 7.5%Remus Pharmaceuticals Limited 7.1%Renosen Pharmaceuticals Private Limited 5.9%Anar Swapnil Shah 5.0%register as filed
2026-06-30
Filing timeline — what the company told the exchange
- Shareholders meeting. Senores Pharmaceuticals Limited has informed the Exchange regarding Scrutinizer Report and Voting results of 09th Annual General Meeting…
28 Sep 2026 · document
- Shareholders meeting. Senores Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 25, 2026…
25 Sep 2026 · document
- Senores Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 20…
24 Sep 2026 · document
- Senores Pharmaceuticals Limited has informed the Exchange about General Updates…
21 Sep 2026 · document
- Senores Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication with respect to the 9th Annual General Meeting of the Company.…
04 Sep 2026 · document
- Shareholders meeting. Senores Pharmaceuticals Limited has informed the Exchange regarding Notice of 9th Annual General Meeting to be held on September 25, 2026…
03 Sep 2026 · document
- Analysts/Institutional Investor Meet/Con. Call Updates. Senores Pharmaceuticals Limited has informed the Exchange about Schedule of meet…
27 Aug 2026 · document
- Copy of Newspaper Publication. Senores Pharmaceuticals Limited has informed the Exchange regarding copy of newspaper publication for pre dispatch of Annual Repo…
27 Aug 2026 · document
Follow this company without reading every document yourself.
Keep its available filings, dated fact checks and disclosure alerts together.
Your saved country sets your market and its research schedule.
Start free — first week on us →
India ₹149/month · Rest of world US$4.99/month after the free trial · research, not investment
advice · cancel any time